# β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis

> **NCT04379726** · — · UNKNOWN · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 150 (estimated)

## Conditions studied

- Cystic Fibrosis-related Diabetes

## Interventions

- **BEHAVIORAL:** therapeutic optimization

## Key facts

- **NCT ID:** NCT04379726
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2020-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04379726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04379726, "β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04379726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*